Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers.
Study Goal
The researchers aimed to analyze the use of nanoparticulate carriers for improving the bioavailability and delivery of Coenzyme Q10 and other antioxidants for oral administration.
Results Summary
The study highlights the encapsulation of Coenzyme Q10 in advanced nanoparticulate carriers to enhance its absorption and bioavailability, addressing limitations of conventional antioxidant delivery. It suggests that such delivery systems could improve therapeutic outcomes for various diseases linked to oxidative stress.
Population
Not specified (general focus on human pathologies involving oxidative stress).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
antioxidants | decrease | human pathologies | diabetic patients | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #1 |
antioxidants | decrease | aging | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #2 |
antioxidants | decrease | cancer diseases | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #3 |
antioxidants | decrease | Parkinson's | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #4 |
antioxidants | decrease | Alzheimer's | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #5 |
antioxidants | decrease | autoimmune disorders | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #6 |
antioxidants | decrease | inflammation | - | - | gained utmost importance because of their potential as prophylactic and therapeutic agents | #7 |
antioxidants | decrease | absorption profiles | - | limited | have limited absorption profiles, therefore low bioavailability and low concentrations at the target site | #8 |
antioxidants | decrease | bioavailability | - | low | have limited absorption profiles, therefore low bioavailability and low concentrations at the target site | #9 |
antioxidants | decrease | concentrations at the target site | - | low | have limited absorption profiles, therefore low bioavailability and low concentrations at the target site | #10 |
nanoparticulate carriers | increase | encapsulation of drugs and other active ingredients | - | - | successful achievements include the encapsulation | #11 |
nanoparticulate carriers | increase | encapsulation of coenzyme Q10 | - | - | successful achievements include the encapsulation | #12 |
nanoparticulate carriers | increase | encapsulation of vitamin E | - | - | successful achievements include the encapsulation | #13 |
nanoparticulate carriers | increase | encapsulation of vitamin A | - | - | successful achievements include the encapsulation | #14 |
nanoparticulate carriers | increase | encapsulation of resveratrol | - | - | successful achievements include the encapsulation | #15 |
nanoparticulate carriers | increase | encapsulation of polyphenols | - | - | successful achievements include the encapsulation | #16 |
nanoparticulate carriers | increase | encapsulation of curcumin | - | - | successful achievements include the encapsulation | #17 |
nanoparticulate carriers | increase | encapsulation of lycopene | - | - | successful achievements include the encapsulation | #18 |
nanoparticulate carriers | increase | encapsulation of silymarin | - | - | successful achievements include the encapsulation | #19 |
nanoparticulate carriers | increase | encapsulation of superoxide dismutase | - | - | successful achievements include the encapsulation | #20 |
Reactive oxygen species (ROS) are known to cause several human pathologies. For this reason, antioxidants have gained utmost importance because of their potential as prophylactic and therapeutic agents in many diseases. Examples of their application include their use in diabetic patients, as aging drugs, in cancer diseases, Parkinson's, Alzheimer's, autoimmune disorders, and also in inflammation. Antioxidants have limited absorption profiles, therefore low bioavailability and low concentrations at the target site. Efforts have been done towards loading antioxidant molecules in advanced nanoparticulate carriers, e.g., liposomes, polymeric nanoparticles, solid lipid nanoparticles, self-emulsifying drug delivery system. Examples of -successful achievements include the encapsulation of drugs and other active ingredients, e.g., coenzyme Q10, vitamin E and vitamin A, resveratrol and polyphenols, curcumin, lycopene, silymarin, and superoxide dismutase. This review focuses on the comprehensive analysis of using nanoparticulate carriers for loading these molecules for oral administration.